514: CH Metabolic Bone: Use of Anabolic Sequencing in the Treatment of Patients at High Risk for Fracture

Community Speaker(s)

• 

  Felicia Cosman, MD

  Columbia University
  Suffern, NY, United States

  Disclosure(s): Amgen: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Enterabio: Consultant (Ongoing); Radius Health: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Hub Host(s)

• CD

  Chad Deal, MD

  Cleveland Clinic
  Shaker Heights, OH, United States

  Disclosure information not submitted.
• SK

  Sarah Keller, MD

  Cleveland Clinic Foundation
  Cleveland, OH, United States

  Disclosure information not submitted.